Metformin ameliorates treatment of obese type 2 diabetic patients with mental retardation; its effects on eating behavior and serum leptin levels

Experimental and Clinical Endocrinology and Diabetes

Volumn 112, Issue 8, 2004, Pages 422-428

  Komori, T ^a,b   Yoshida, Futoshi ^a,b   Nakamura, J ^b   Miyazaki, S ^a   Miura, H ^b   Iguchi, A ^b  

^a INSTITUTE FOR DEVELOPMENTAL RESEARCH   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Biguanides; Leptin; Metformin; Obesity; Type 2 diabetes

Indexed keywords

C PEPTIDE; CHOLESTEROL; GLIBENCLAMIDE; GLUCOSE; GLYCORAN; HEMOGLOBIN A1C; INSULIN; LEPTIN; METFORMIN; SULFONYLUREA DERIVATIVE; TRIACYLGLYCEROL;

ADULT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMORBIDITY; CONFERENCE PAPER; DRUG EFFICACY; FEEDING BEHAVIOR; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MALE; MENTAL DEFICIENCY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; ENERGY INTAKE; FEEDING BEHAVIOR; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LEPTIN; MALE; MENTAL RETARDATION; METFORMIN; OBESITY; QUESTIONNAIRES; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 4744350434     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-821187     Document Type: Conference Paper

References (25)

1. Bailey CJ, Turner RC. Metformin. New Engl J Med 1996; 334: 574-579
2. Borst SE, Snellen HG, Lai HL. Metformin treatment enhances insulin-stimulated glucose transport in skeletal muscle of Sprague-Dawley rats. Life Sci 2000; 67: 165-174
3. Caprio S, Tamborlane W, Silver D, Robinson C, Leibel R, McCarthy S, Grozman A, Belous A, Maggs D, Sherwin RS. Hyperleptinemia: an early sign of juvenile obesity. Relations to body fat depots and insulin concentrations. Am J Physiol 1996; 271: E626-630
4. Carlsen SM, Grill V, Folling I. Evidence for dissociation of insulin- and weight-reducing effects of metformin in non-diabetic male patients with coronary heart disease. Diab Res Clin Pract 1998; 39: 47-54
5. Clement K, Garner C, Hager J, Philippi A, LeDuc C, Carey A, Harris TJ, Jury C, Cardon LR, Basdevant A, Demenais F, Guy-Grand B, North M, Froguel P. Indication for linkage of the human OB gene region with extreme obesity. Diabetes 1996; 45: 687-690
6. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bougneres P, Lebouc Y, Froguel P, Guy-Grand B. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998; 392: 398-401
7. DeFronzo RA, Goodman AM et al. Efficacy of metformin in patients with noninsulin-dependent diabetes mellitus. New Engl J Med 1998; 333: 541-549
8. Gielkens HA, Verkijk M, Lam WF, Lamers CB, Masclee AA. Effects of hyperglycemia and hyperinsulinemia on satiety in humans. Metabolism 1998; 47: 321-324
9. Gunay-Aygun M, Cassidy SB, Nicholls RD. Prader-Willi and other syndromes associated with obesity and mental retardation. Behav Genet 1997; 27: 307-324
10. Hattori A, Uemura K, Miura H, Ueda M, Iguchi A. Gender-related difference in relationship between insulin resistance and serum leptin level in Japanese type 2 diabetic subjects. Endocr J 2000; 47: 615-621
11. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomized placebo-controlled trial. Lancet 2002; 360 (9326): 7-22
12. Kellerer M, Lammers R, Fitshe A, Haring HU. Insulin inhibits leptin receptor signaling in HEK293 cells at the level of jauns kinase-2: a potential mechanism for hyperinsulinemia-associated leptin resistance. Diabetologia 2001; 44: 1125-1132
13. Lee A, Morley JE. Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes. Obes Res 1998; 6: 47-53
14. Lee AJ. Metformin in noninsulin-dependent diabetes mellitus. Pharmacotherapy 1996; 16: 327-351
15. Makimattila S, Nikkila K, Yki-Jarvinen H. Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus. Diabetologia. 1999; 42: 406-412
16. Maruhama Y, Abe R, Okuguchi F, Ohneda A. Dietary intake and hyperlipidemia in controlled diabetic outpatients. Diabetes 1997; 26: 94-99
17. Matsumoto K, Miyake S, Yano M, Ueki Y, Yamaguchi Y, Akazawa S, Tominaga Y. Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects. Diabetes Care 1997; 20: 1562-1568
18. Paolisso G, Amato L, Eccellente R, Gambardella A, Tagliamonte MR, Varricchio G, Carella C, Giugliano D, D'Onofrio F. Effect of metformin on food intake in obese subjects. Europ J of Clin Invest 1998; 28: 441-446
19. Patane G, Piro S, Rabuazzo AM, Anello M, Vigneri R, Purello F. Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells. Diabetes 2000; 49: 735-740
20. Saladin R, De Vos P, Guerre-Millo M, Leturque A, Girard J, Staels B, Auwerx J. Transient increase in obese gene expression after food intake or insulin administration. Nature 1995; 377: 527-529
21. Solomon SS, Mishra SK, Cwik C, Rajanna B, Postlethwaite AE. Pioglitazone and metformin reverse insulin resistance induced by tumor necrosis factor-alpha in liver cells. Horm Metab Res 1997; 29: 379-382
22. Tommis AD. Diabetes. Br Med Bull 2001; 59: 159-172
23. Stumvoll M, Nurjhan N, Perriello G, Dailey G, Gerich JE. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. New Engl J Med 1995; 333: 550-554
24. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in over-weight patients with type 2 diabetes (UKPDS). Lancet 1998; 352: 854-865
25. Wang J, Liu R, Hawkins M, Barzilai N, Rossetti L. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature 1998; 393: 684-688